Exchange: NASDAQ·Updated 05:18 PM EDT
News
all
press releases
Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee
Afya Limited (Nasdaq: AFYA; B3: A2FY34) (Afya or the Company), the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee. Mr. Suhara, who...
Business Wire
More News
Implied Volatility Surging for Afya Stock Options
Investors need to pay close attention to AFYA stock based on the movements in the options market lately.
Zacks
Afya Limited Announces Results of Annual General Meeting Held on June 22, 2026
Afya Limited, or Afya (Nasdaq: AFYA) announced today that the resolution set out in its Notice of Annual General Meeting dated June 2, 2026 was duly passed at its Annual General Meeting held today: the approval and ratification of Afyas financial statements as of and for the fiscal year ended...
Business Wire
Are Investors Undervaluing Afya (AFYA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks
AFYA vs. APEI: Which Stock Is the Better Value Option?
AFYA vs. APEI: Which Stock Is the Better Value Option?
Zacks
Afya Limited Releases 2025 Integrated Report
Afya Limited (Nasdaq: AFYA; B3: A2FY34) (Afya or the Company), the leading medical education group and medical practice solutions provider in Brazil, announces the release of its 2025 Integrated Report. The document presents Afya's trajectory throughout 2025, representing the Company's best...
Business Wire
Should Value Investors Buy Afya (AFYA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks
Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 25.6% in Afya (AFYA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
AFYA or APEI: Which Is the Better Value Stock Right Now?
AFYA vs. APEI: Which Stock Is the Better Value Option?
Zacks
Are Investors Undervaluing Afya (AFYA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks

Advertisement|Remove ads.